Researchers in Germany found a “relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician and patient-rated akathisia” in patients with a first-episode diagnosis of schizophrenia who were treated with Haldol or Risperdal. Results were published online May 21, 2012 in Pharmocopsychiatry.
Seemuller, F. Lewitzka, U. Bauer, M. et. al; The Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia Treated with Haloperidol or Risperidone, Pharmacopsychiatry, published online May 21, 2012
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.